{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:24:55Z","timestamp":1784125495063,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"from Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["404256\/2021-0 and 310606\/2021-7"],"award-info":[{"award-number":["404256\/2021-0 and 310606\/2021-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","award":["2021TR1543"],"award-info":[{"award-number":["2021TR1543"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11302-024-10002-5","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T09:02:20Z","timestamp":1710752540000},"page":"581-593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cutaneous melanoma and purinergic modulation by phenolic compounds"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0384-9934","authenticated-orcid":false,"given":"Ge\u00f3rgia","family":"de Carvalho Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1770-4736","authenticated-orcid":false,"given":"Jo\u00e3o Victor","family":"Coiado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4286-5083","authenticated-orcid":false,"given":"Vit\u00f3ria Capelli","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8557-248X","authenticated-orcid":false,"given":"Brenno Bianchoni","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-4980","authenticated-orcid":false,"given":"Margarete Dulce","family":"Bagatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"10002_CR1","unstructured":"Lopes A, Chammas R, Iyeyasu H (2013) Oncologia para a gradua\u00e7\u00e3o. Lemar, S\u00e3o Paulo"},{"key":"10002_CR2","doi-asserted-by":"publisher","unstructured":"Leonardi G, Falzone L, Salemi R, Zangh\u00ef\u00bf\u00bd A, Spandidos D, Mccubrey J, et al. Cutaneous melanoma: from pathogenesis to therapy (Review). Int J Oncol 2018. https:\/\/doi.org\/10.3892\/ijo.2018.4287","DOI":"10.3892\/ijo.2018.4287"},{"key":"10002_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N et al (2022) European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics: Update 2022. Eur J Cancer 170:236\u201355. https:\/\/doi.org\/10.1016\/j.ejca.2022.03.008","journal-title":"Eur J Cancer"},{"key":"10002_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11302-021-09821-7","volume":"18","author":"GB da Silva","year":"2022","unstructured":"da Silva GB, Yamauchi MA, Zanini D, Bagatini MD (2022) Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling. Purinergic Signal 18:61\u201381. https:\/\/doi.org\/10.1007\/s11302-021-09821-7","journal-title":"Purinergic Signal"},{"key":"10002_CR5","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.3390\/molecules28176251","volume":"28","author":"J Baloghov\u00e1","year":"2023","unstructured":"Baloghov\u00e1 J, Michalkov\u00e1 R, Baranov\u00e1 Z, Moj\u017ei\u0161ov\u00e1 G, Fed\u00e1kov\u00e1 Z, Moj\u017ei\u0161 J (2023) Spice-derived phenolic compounds: potential for skin cancer prevention and therapy. Molecules 28:6251. https:\/\/doi.org\/10.3390\/molecules28176251","journal-title":"Molecules"},{"key":"10002_CR6","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.3390\/molecules28052381","volume":"28","author":"T Murai","year":"2023","unstructured":"Murai T, Matsuda S (2023) The chemopreventive effects of chlorogenic acids, phenolic compounds in coffee, against inflammation, cancer, and neurological diseases. Molecules 28:2381. https:\/\/doi.org\/10.3390\/molecules28052381","journal-title":"Molecules"},{"key":"10002_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.32725\/jab.2021.024","volume":"19","author":"MA Mahmoud","year":"2021","unstructured":"Mahmoud MA, Okda TM, Omran GA, Abd-Alhaseeb MM (2021) Rosmarinic acid suppresses inflammation, angiogenesis, and improves paclitaxel induced apoptosis in a breast cancer model via NF3 \u03baB-p53-caspase-3 pathways modulation. J Appl Biomed 19:202\u20139. https:\/\/doi.org\/10.32725\/jab.2021.024","journal-title":"J Appl Biomed"},{"key":"10002_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173419","volume":"885","author":"SS Messeha","year":"2020","unstructured":"Messeha SS, Zarmouh NO, Asiri A, Soliman KFA (2020) Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells. Eur J Pharmacol 885:173419. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173419","journal-title":"Eur J Pharmacol"},{"key":"10002_CR9","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.31557\/APJCP.2021.22.10.3189","volume":"22","author":"T Abdelwahab","year":"2021","unstructured":"Abdelwahab T, Abdelhamed R, Ali E, Mansour N, Abdalla M (2021) Evaluation of silver nanoparticles caffeic acid complex compound as new potential therapeutic agent against cancer incidence in mice. Asian Pacific J Cancer Prev 22:3189\u2013201. https:\/\/doi.org\/10.31557\/APJCP.2021.22.10.3189","journal-title":"Asian Pacific J Cancer Prev"},{"key":"10002_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154860","volume":"116","author":"J-C Tseng","year":"2023","unstructured":"Tseng J-C, Wang B-J, Wang Y-P, Kuo Y-Y, Chen J-K, Hour T-C et al (2023) Caffeic acid phenethyl ester suppresses EGFR\/FAK\/Akt signaling, migration, and tumor growth of prostate cancer cells. Phytomedicine 116:154860. https:\/\/doi.org\/10.1016\/j.phymed.2023.154860","journal-title":"Phytomedicine"},{"key":"10002_CR11","doi-asserted-by":"publisher","first-page":"e0232832","DOI":"10.1371\/journal.pone.0232832","volume":"15","author":"C Chen","year":"2020","unstructured":"Chen C, Kuo Y-H, Lin C-C, Chao C-Y, Pai M-H, Chiang EPI et al (2020) Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo. PLoS One 15:e0232832. https:\/\/doi.org\/10.1371\/journal.pone.0232832","journal-title":"PLoS One"},{"key":"10002_CR12","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.3390\/molecules28073107","volume":"28","author":"AR Caetano","year":"2023","unstructured":"Caetano AR, Oliveira RD, Celeiro SP, Freitas AS, Cardoso SM, Gon\u00e7alves MST et al (2023) Phenolic compounds contribution to portuguese propolis anti-melanoma activity. Molecules 28:3107. https:\/\/doi.org\/10.3390\/molecules28073107","journal-title":"Molecules"},{"key":"10002_CR13","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3390\/cells12192373","volume":"12","author":"JV Kichina","year":"2023","unstructured":"Kichina JV, Maslov A, Kandel ES (2023) PAK1 and therapy resistance in melanoma. Cells 12:2373. https:\/\/doi.org\/10.3390\/cells12192373","journal-title":"Cells"},{"key":"10002_CR14","doi-asserted-by":"publisher","unstructured":"Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, et al. ATP and cancer immunosurveillance. EMBO J 2021;40. https:\/\/doi.org\/10.15252\/embj.2021108130.","DOI":"10.15252\/embj.2021108130"},{"key":"10002_CR15","doi-asserted-by":"publisher","first-page":"119237","DOI":"10.1016\/j.bbamcr.2022.119237","volume":"1869","author":"V Vultaggio-Poma","year":"2022","unstructured":"Vultaggio-Poma V, Falzoni S, Salvi G, Giuliani AL, Di Virgilio F (2022) Signalling by extracellular nucleotides in health and disease. Biochimica et Biophysica Acta (BBA) Mol Cell Res 1869:119237. https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119237","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Cell Res"},{"key":"10002_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102137","volume":"47","author":"LEB Savio","year":"2021","unstructured":"Savio LEB, Leite-Aguiar R, Alves VS, Coutinho-Silva R, Wyse ATS (2021) Purinergic signaling in the modulation of redox biology. Redox Biol 47:102137. https:\/\/doi.org\/10.1016\/j.redox.2021.102137","journal-title":"Redox Biol"},{"key":"10002_CR17","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K (2021) Reactive oxygen species in cancer: current findings and future directions. Cancer Sci 112:3945\u20133952. https:\/\/doi.org\/10.1111\/cas.15068","journal-title":"Cancer Sci"},{"key":"10002_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s11302-022-09909-8","volume":"19","author":"JLG da Silva","year":"2023","unstructured":"da Silva JLG, Viana AR, Passos DF, Krause LMF, Miron VV, Schetinger MRC et al (2023) Istradefylline modulates purinergic enzymes and reduces malignancy-associated factors in B16F10 melanoma cells. Purinergic Signal 19:633\u2013650. https:\/\/doi.org\/10.1007\/s11302-022-09909-8","journal-title":"Purinergic Signal"},{"key":"10002_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114687","volume":"162","author":"S Ijaz","year":"2023","unstructured":"Ijaz S, Iqbal J, Abbasi BA, Ullah Z, Yaseen T, Kanwal S et al (2023) Rosmarinic acid and its derivatives: current insights on anticancer potential and other biomedical applications. Biomed Pharmacother 162:114687. https:\/\/doi.org\/10.1016\/j.biopha.2023.114687","journal-title":"Biomed Pharmacother"},{"key":"10002_CR20","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.3390\/nu15194297","volume":"15","author":"MDK Azhar","year":"2023","unstructured":"Azhar MDK, Anwar S, Hasan GM, Shamsi A, Islam A, Parvez S et al (2023) Comprehensive insights into biological roles of rosmarinic acid: implications in diabetes, cancer and neurodegenerative diseases. Nutrients 15:4297. https:\/\/doi.org\/10.3390\/nu15194297","journal-title":"Nutrients"},{"key":"10002_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/carcin\/bgh034","volume":"25","author":"N Osakabe","year":"2003","unstructured":"Osakabe N (2003) Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis 25:549\u2013557. https:\/\/doi.org\/10.1093\/carcin\/bgh034","journal-title":"Carcinogenesis"},{"key":"10002_CR22","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1080\/21655979.2021.1941699","volume":"12","author":"L Huang","year":"2021","unstructured":"Huang L, Chen J, Quan J, Xiang D (2021) Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17\/EGFR\/AKT\/GSK3\u03b2 axis. Bioengineered 12:3065\u20133076. https:\/\/doi.org\/10.1080\/21655979.2021.1941699","journal-title":"Bioengineered"},{"key":"10002_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47:15\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.020","journal-title":"Immunity"},{"key":"10002_CR24","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.3390\/ijms21186855","volume":"21","author":"D Strassheim","year":"2020","unstructured":"Strassheim D, Verin A, Batori R, Nijmeh H, Burns N, Kovacs-Kasa A et al (2020) P2Y purinergic receptors, endothelial dysfunction, and cardiovascular diseases. Int J Mol Sci 21:6855. https:\/\/doi.org\/10.3390\/ijms21186855","journal-title":"Int J Mol Sci"},{"key":"10002_CR25","doi-asserted-by":"publisher","unstructured":"Alam M, Ahmed S, Elasbali AM, Adnan M, Alam S, Hassan MdI, et al. Therapeutic implications of caffeic acid in cancer and neurological diseases. Front Oncol 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.860508.","DOI":"10.3389\/fonc.2022.860508"},{"key":"10002_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2010.05.018","volume":"188","author":"SK Kudugunti","year":"2010","unstructured":"Kudugunti SK, Vad NM, Whiteside AJ, Naik BU, Yusuf MohdA, Srivenugopal KS et al (2010) Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines. Chem Biol Interact 188:1\u201314. https:\/\/doi.org\/10.1016\/j.cbi.2010.05.018","journal-title":"Chem Biol Interact"},{"key":"10002_CR27","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s11033-019-04658-1","volume":"46","author":"LP Pelinson","year":"2019","unstructured":"Pelinson LP, Assmann CE, Palma TV, da Cruz IBM, Pillat MM, M\u00e2nica A et al (2019) Antiproliferative and apoptotic effects of caffeic acid on SK-Mel-28 human melanoma cancer cells. Mol Biol Rep 46:2085\u20132092. https:\/\/doi.org\/10.1007\/s11033-019-04658-1","journal-title":"Mol Biol Rep"},{"key":"10002_CR28","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.3390\/ijms23073859","volume":"23","author":"M Kimsa-Dudek","year":"2022","unstructured":"Kimsa-Dudek M, Synowiec-Wojtarowicz A, Krawczyk A, Kosowska A, Kimsa-Furdzik M, Francuz T (2022) The apoptotic effect of caffeic or chlorogenic acid on the C32 cells that have simultaneously been exposed to a static magnetic field. Int J Mol Sci 23:3859. https:\/\/doi.org\/10.3390\/ijms23073859","journal-title":"Int J Mol Sci"},{"key":"10002_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.fct.2013.02.030","volume":"56","author":"J Anwar","year":"2013","unstructured":"Anwar J, Spanevello RM, Pimentel VC, Gutierres J, Thom\u00e9 G, Cardoso A et al (2013) Caffeic acid treatment alters the extracellular adenine nucleotide hydrolysis in platelets and lymphocytes of adult rats. Food Chem Toxicol 56:459\u2013466. https:\/\/doi.org\/10.1016\/j.fct.2013.02.030","journal-title":"Food Chem Toxicol"},{"key":"10002_CR30","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1182\/blood.2019003977","volume":"137","author":"DL Tao","year":"2021","unstructured":"Tao DL, Tassi Yunga S, Williams CD, McCarty OJT (2021) Aspirin and antiplatelet treatments in cancer. Blood 137:3201\u20133211. https:\/\/doi.org\/10.1182\/blood.2019003977","journal-title":"Blood"},{"key":"10002_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119421","volume":"277","author":"MFV Castro","year":"2021","unstructured":"Castro MFV, Stefanello N, Assmann CE, Baldissarelli J, Bagatini MD, da Silva AD et al (2021) Modulatory effects of caffeic acid on purinergic and cholinergic systems and oxi-inflammatory parameters of streptozotocin-induced diabetic rats. Life Sci 277:119421. https:\/\/doi.org\/10.1016\/j.lfs.2021.119421","journal-title":"Life Sci"},{"key":"10002_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.circir.2015.04.015","volume":"83","author":"VM Valdespino-G\u00f3mez","year":"2015","unstructured":"Valdespino-G\u00f3mez VM, Valdespino-Castillo PM, Valdespino-Castillo VE (2015) Interacci\u00f3n de las v\u00edas de se\u00f1alizaci\u00f3n intracelulares participantes en la proliferaci\u00f3n celular: potencial blanco de intervencionismo terap\u00e9utico. Cir Cir 83:165\u2013174. https:\/\/doi.org\/10.1016\/j.circir.2015.04.015","journal-title":"Cir Cir"},{"key":"10002_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41419-021-04378-0","volume":"12","author":"A Pegoraro","year":"2021","unstructured":"Pegoraro A, De Marchi E, Ferracin M, Orioli E, Zanoni M, Bassi C et al (2021) P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells. Cell Death Dis 12:1088. https:\/\/doi.org\/10.1038\/s41419-021-04378-0","journal-title":"Cell Death Dis"},{"key":"10002_CR34","doi-asserted-by":"publisher","unstructured":"Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F, et al. P2X7 in cancer: from molecular mechanisms to therapeutics. Front Pharmacol 2020;11. https:\/\/doi.org\/10.3389\/fphar.2020.00793.","DOI":"10.3389\/fphar.2020.00793"},{"key":"10002_CR35","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1038\/s41388-019-0684-y","volume":"38","author":"E De Marchi","year":"2019","unstructured":"De Marchi E, Orioli E, Pegoraro A, Sangaletti S, Portararo P, Curti A et al (2019) The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene 38:3636\u20133650. https:\/\/doi.org\/10.1038\/s41388-019-0684-y","journal-title":"Oncogene"},{"key":"10002_CR36","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/bib\/bby054","volume":"20","author":"L Chen","year":"2019","unstructured":"Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G (2019) Trends in the development of miRNA bioinformatics tools. Brief Bioinform 20:1836\u20131852. https:\/\/doi.org\/10.1093\/bib\/bby054","journal-title":"Brief Bioinform"},{"key":"10002_CR37","doi-asserted-by":"publisher","first-page":"20826","DOI":"10.18632\/oncotarget.24846","volume":"9","author":"M Tucci","year":"2018","unstructured":"Tucci M, Mannavola F, Passarelli A, Stucci LS, Cives M, Silvestris F (2018) Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity. Oncotarget 9:20826\u201337. https:\/\/doi.org\/10.18632\/oncotarget.24846","journal-title":"Oncotarget"},{"key":"10002_CR38","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/cancers14051116","volume":"14","author":"JC Rotondo","year":"2022","unstructured":"Rotondo JC, Mazziotta C, Lanzillotti C, Stefani C, Badiale G, Campione G et al (2022) The role of purinergic P2X7 receptor in inflammation and cancer: novel molecular insights and clinical applications. Cancers (Basel) 14:1116. https:\/\/doi.org\/10.3390\/cancers14051116","journal-title":"Cancers (Basel)"},{"key":"10002_CR39","doi-asserted-by":"publisher","unstructured":"Savio LEB, de Andrade Mello P, da Silva CG, Coutinho-Silva R. The P2X7 receptor in inflammatory diseases: angel or demon? Front Pharmacol 2018;9. https:\/\/doi.org\/10.3389\/fphar.2018.00052.","DOI":"10.3389\/fphar.2018.00052"},{"key":"10002_CR40","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-19-3807","volume":"80","author":"A Romagnani","year":"2020","unstructured":"Romagnani A, Rottoli E, Mazza EMC, Rezzonico-Jost T, De Ponte CB, Proietti M et al (2020) P2X7 receptor activity limits accumulation of T cells within tumors. Cancer Res 80:3906\u20133919. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3807","journal-title":"Cancer Res"},{"key":"10002_CR41","first-page":"2765","volume":"11","author":"C Lei","year":"2019","unstructured":"Lei C, Fan Y, Peng X, Gong X, Shao L (2019) P2Y11R regulates cytotoxicity of HBV X protein (HBx) in human normal hepatocytes. Am J Transl Res 11:2765\u20132774","journal-title":"Am J Transl Res"},{"key":"10002_CR42","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1038\/s41467-021-25749-3","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang C, Lei L, Collins JWM, Briones M, Ma L, Sturdevant GL et al (2021) Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor. Nat Commun 12:5454. https:\/\/doi.org\/10.1038\/s41467-021-25749-3","journal-title":"Nat Commun"},{"key":"10002_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jaci.2014.02.002","volume":"134","author":"RJ Snelgrove","year":"2014","unstructured":"Snelgrove RJ, Gregory LG, Peir\u00f3 T, Akthar S, Campbell GA, Walker SA et al (2014) Alternaria-derived serine protease activity drives IL-33\u2013mediated asthma exacerbations. J Allergy Clin Immunol 134:583-592.e6. https:\/\/doi.org\/10.1016\/j.jaci.2014.02.002","journal-title":"J Allergy Clin Immunol"},{"key":"10002_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-017-2573-y","volume":"11","author":"J-H Quan","year":"2018","unstructured":"Quan J-H, Huang R, Wang Z, Huang S, Choi I-W, Zhou Y et al (2018) P2X7 receptor mediates NLRP3-dependent IL-1\u03b2 secretion and parasite proliferation in Toxoplasma gondii-infected human small intestinal epithelial cells. Parasit Vectors 11:1. https:\/\/doi.org\/10.1186\/s13071-017-2573-y","journal-title":"Parasit Vectors"},{"key":"10002_CR45","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41419-019-2010-6","volume":"10","author":"L Kloss","year":"2019","unstructured":"Kloss L, Dollt C, Schledzewski K, Krewer A, Melchers S, Manta C et al (2019) ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12. Cell Death Dis 10:760. https:\/\/doi.org\/10.1038\/s41419-019-2010-6","journal-title":"Cell Death Dis"},{"key":"10002_CR46","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1152\/physrev.00035.2007","volume":"88","author":"F Malavasi","year":"2008","unstructured":"Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E et al (2008) Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology. Physiol Rev 88:841\u2013886. https:\/\/doi.org\/10.1152\/physrev.00035.2007","journal-title":"Physiol Rev"},{"key":"10002_CR47","doi-asserted-by":"publisher","first-page":"25602","DOI":"10.18632\/oncotarget.4693","volume":"6","author":"F Morandi","year":"2015","unstructured":"Morandi F, Morandi B, Horenstein AL, Chillemi A, Quarona V, Zaccarello G et al (2015) A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation. Oncotarget 6:25602\u201318. https:\/\/doi.org\/10.18632\/oncotarget.4693","journal-title":"Oncotarget"},{"key":"10002_CR48","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","volume":"8","author":"L Chen","year":"2018","unstructured":"Chen L, Diao L, Yang Y, Yi X, Rodriguez BL, Li Y et al (2018) CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1\/PD-L1 blockade. Cancer Discov 8:1156\u20131175. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1033","journal-title":"Cancer Discov"},{"key":"10002_CR49","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","volume":"20","author":"AK Moesta","year":"2020","unstructured":"Moesta AK, Li X-Y, Smyth MJ (2020) Targeting CD39 in cancer. Nat Rev Immunol 20:739\u2013755. https:\/\/doi.org\/10.1038\/s41577-020-0376-4","journal-title":"Nat Rev Immunol"},{"key":"10002_CR50","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.3390\/ijms22158068","volume":"22","author":"E Timperi","year":"2021","unstructured":"Timperi E, Barnaba V (2021) CD39 regulation and functions in T cells. Int J Mol Sci 22:8068. https:\/\/doi.org\/10.3390\/ijms22158068","journal-title":"Int J Mol Sci"},{"key":"10002_CR51","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/eji.201545939","volume":"46","author":"A Noble","year":"2016","unstructured":"Noble A, Mehta H, Lovell A, Papaioannou E, Fairbanks L (2016) IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8 + T cells. Eur J Immunol 46:1438\u20131448. https:\/\/doi.org\/10.1002\/eji.201545939","journal-title":"Eur J Immunol"},{"key":"10002_CR52","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","volume":"3","author":"J Bastid","year":"2015","unstructured":"Bastid J, Regairaz A, Bonnefoy N, D\u00e9jou C, Giustiniani J, Laheurte C et al (2015) Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. Cancer Immunol Res 3:254\u2013265. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0018","journal-title":"Cancer Immunol Res"},{"key":"10002_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Simoni Y, Becht E, Fehlings M, Loh CY, Koo S-L, Teng KWW et al (2018) Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557:575\u2013579. https:\/\/doi.org\/10.1038\/s41586-018-0130-2","journal-title":"Nature"},{"key":"10002_CR54","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccell.2016.06.025","volume":"30","author":"A Young","year":"2016","unstructured":"Young A, Ngiow SF, Barkauskas DS, Sult E, Hay C, Blake SJ et al (2016) Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses. Cancer Cell 30:391\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2016.06.025","journal-title":"Cancer Cell"},{"key":"10002_CR55","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-19-0833","volume":"8","author":"S Chen","year":"2020","unstructured":"Chen S, Akdemir I, Fan J, Linden J, Zhang B, Cekic C (2020) The expression of adenosine A2B receptor on antigen-presenting cells suppresses CD8+ T-cell responses and promotes tumor growth. Cancer Immunol Res 8:1064\u20131074. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0833","journal-title":"Cancer Immunol Res"},{"key":"10002_CR56","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MKK et al (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci 103:13132\u201313137. https:\/\/doi.org\/10.1073\/pnas.0605251103","journal-title":"Proc Natl Acad Sci"},{"key":"10002_CR57","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11302-021-09811-9","volume":"17","author":"S JanhoDitHreich","year":"2021","unstructured":"JanhoDitHreich S, Benzaquen J, Hofman P, Vouret-Craviari V (2021) To inhibit or to boost the ATP\/P2RX7 pathway to fight cancer\u2014that is the question. Purinergic Signal 17:619\u201331. https:\/\/doi.org\/10.1007\/s11302-021-09811-9","journal-title":"Purinergic Signal"},{"key":"10002_CR58","first-page":"1246","volume":"12","author":"P Gan","year":"2021","unstructured":"Gan P, Liu C, Wu H, Dong Xin-Tong, Ke J, Chen F (2021) The role of HIF-VEGF-Ang-2 signal transduction-mediated synovial angiogenesis in rheumatoid arthritis \/ \u836f\u5b66\u5b66\u62a5. Acta Pharmaceutica Sinica 12:1246\u201352","journal-title":"Acta Pharmaceutica Sinica"},{"key":"10002_CR59","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","volume":"65","author":"T Tammela","year":"2005","unstructured":"Tammela T, Enholm B, Alitalo K, Paavonen K (2005) The biology of vascular endothelial growth factors. Cardiovasc Res 65:550\u2013563. https:\/\/doi.org\/10.1016\/j.cardiores.2004.12.002","journal-title":"Cardiovasc Res"},{"key":"10002_CR60","unstructured":"Romagnoli GG (2007) Fatores de crescimento e citocinas envolvidos na angiog\u00eanese de melanoma em animais selecionados pela intensidade da resposta inflamat\u00f3ria aguda. Dissertation, Universidade Estadual Paulista (UNESP)"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-024-10002-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-024-10002-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-024-10002-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T14:10:20Z","timestamp":1731420620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-024-10002-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10002"],"URL":"https:\/\/doi.org\/10.1007\/s11302-024-10002-5","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"An informed consent and a consent to publish were obtained from each of the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}